Northwestern University Medical Center

Chicago, Illinois 60611

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Hematology, Oncology Clinical Trial
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)
Status: Enrolling, Phase
Updated: 12/31/1969
Northwestern University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Epidermolysis Bullosa Clinical Trial
Study of Diacerein After Maximum Use in Patients With EB
Status: Enrolling, Phase I
Updated: 12/31/1969
Northwestern University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials